% | $
Quotes you view appear here for quick access.

Amylin Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • drsmagic drsmagic Jun 5, 2001 4:33 PM Flag

    what is driving price

    When the stock price rises on triple the normal volume -means only one thing. People in the know are buying based on insider knowledge of expected good news. This has to relate to the phase 2 results of exendin, they must be really good.- FDA advisory approval of symlin wont drive the price up- that will happen after the July 26th meeting.
    Amylin must know that this is a killer drug that is why they are forging ahead developing a LAR version before the regular version has been approved. If there was any doubt on the efficacy of this drug they would not commit resources for a LAR version. Comments on this hypothesis welcome